Comparison of citrate anticoagulation during plasma exchange with different replacement solutions

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 4, 2009, Pages 322-326

  Antonič, Manja ^a   Gubenšek, Jakob ^a   Buturović Ponikvar, Jadranka ^a   Ponikvar, Rafael ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Anticoagulation; Citrate; Hemodialysis; Metabolic alkalosis; Plasma exchange

Indexed keywords

BICARBONATE; CALCIUM ION; CITRATE TRISODIUM; FRESH FROZEN PLASMA; HUMAN ALBUMIN;

ADULT; AGED; ANTICOAGULATION; BLOOD FLOW; BLOOD PH; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROL GROUP; CONTROLLED STUDY; DRUG CLEARANCE; FEMALE; HEMODIALYSIS; HUMAN; MALE; METABOLIC ALKALOSIS; PH MEASUREMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SUBSTITUTION THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ALKALOSIS; ANTICOAGULANTS; BICARBONATES; CALCIUM; CITRATES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; PLASMA SUBSTITUTES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68849097787     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00733.x     Document Type: Conference Paper

References (12)

1. Szczepiorkowski ZM, Bandarenko N, Kim HC et al. American Society for Apheresis; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 22 : 106 75.
2. Samtleben W, Mistry-Burchardi N, Hartmann B, Lennertz A, Bosch T. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001 5 : 351 7.
3. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001 89 : 233 6.
4. MH M, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 1994 23 : 817 27.
5. P'ng SS, Hughes AS, Cooney JP. A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura. Ther Apher Dial 2008 12 : 78 81.
6. van der Meulen J, Janssen MJ, Langendijk PN et al. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis. Clin Nephrol 1992 37 : 36 41.
7. Marques MB, Huang ST. Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange. J Clin Apher 2001 16 : 120 4.
8. Nagai Y, Itabashi M, Mizutani M. et al. A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura. Ther Apher Dial 2008 12 : 86 90.
9. van der Meulen J, Janssen MF, Oe PL. Cardiac arrest during rapid plasma exchange for haemolytic uraemic syndrome. Nephrol Dial Transplant 1994 9 : 1841.
10. Buturović-Ponikvar J, Marn Pernat A, Ponikvar R. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load. Ther Apher Dial 2005 9 : 258 61.
11. Evenepoel P, Maes B, Vanwalleghem J, Kuypers D, Messiaen T, Vanrenterghem Y. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis 2002 39 : 315 23.
12. Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Böhler J. Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 2009 24 : 2244 51.